Dramatic rise in high blood pressure contributes to many U.S. deaths

the ONA take:

Deaths related to high blood pressure have sharply risen over the last 13 years, according to recent data from the CDC’s National Center for Health Statistics.

In the CDC’s report, hypertension-related deaths was found to have increased by 61.8 percent from 2000 to 2013, and the rate of incidence rose for both sexes aged 45 or older.

The researchers, who pulled their data from national cause-of-death files, counted any mention of hypertension on death certificates as a hypertension-related death.

Overall, one out of six hypertension-related deaths was due to high blood pressure as the underlying cause.

However, the report also found that the proportion of deaths where heart disease was the underlying cause of death had dropped by about 6 percent, while those with stroke as an underlying cause dropped by about 5 percent. High blood pressure was still a contributing factor to other deaths.

Deaths as a result of heart disease, stroke, cancer, and diabetes that mentioned hypertension in certificates made up 65 percent of counted deaths in 2000, and 54 percent of those in 2013.

Dramatic rise in high blood pressure contributes to many U.S. deaths
Deaths related to high blood pressure have sharply risen over the last 13 years.
Deaths related to high blood pressure, have risen significantly over the last 13 years, according to new federal data.
READ FULL ARTICLE From Time
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs